Direct Oral Anticoagulant Therapy With A Fully Magnetically Levitated LVAD and Bridging to Heart Transplantation: A DOT-HM3 Study Analysis-Reference-Cited by-同舟云学术

Direct Oral Anticoagulant Therapy With A Fully Magnetically Levitated LVAD and Bridging to Heart Transplantation: A DOT-HM3 Study Analysis

Published:2024-05 Issue: Volume: Page:
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

NETUKA IVAN,TUCANOVA ZUZANA,MEHRA MANDEEP R.^ORCID

Funder

Abbott Laboratories

Abbott Vascular

Publisher

Elsevier BV

Reference8 articles.

1. Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial;Mehra;JAMA,2022

2. Increased thromboembolic events with dabigatran compared with vitamin K antagonism in left ventricular assist device patients: a randomized controlled pilot trial;Andreas;Circ Heart Fail,2017

3. A Prospective randomized trial of direct oral anticoagulant therapy with a fully magnetically levitated LVAD: the DOT-HM3 study;Netuka;Circulation,2024

4. ARIES-HM3 Investigators. Aspirin and hemocompatibility events with a left ventricular assist device in advanced heart failure: the ARIES-HM3 randomized clinical trial;Mehra;JAMA,2023

5. Andexanet alfa for reversal of factor Xa inhibitors: a critical review of the evidence;Abdulrehman;Future Cardiol,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durable left ventricular assist devices as a bridge to transplantation: what to expect along the way?;Expert Review of Medical Devices;2024-08-28

2. New Advances in Medical Management of Left Ventricular Assist Devices Recipients;Current Treatment Options in Cardiovascular Medicine;2024-08-07

3. Antithrombotic Strategies With Left Ventricular Assist Devices;Journal of Cardiac Failure;2024-08